1. Hereditary Thrombophilia and Venous Thromboembolism: Critical Evaluation of the Clinical Implications of Screening
- Author
-
Lucia Mazzolai and M.A. Duchosal
- Subjects
medicine.medical_specialty ,FV Leiden ,Hereditary thrombophilia ,Complex disease ,Thrombophilia ,Risk Assessment ,Recurrence ,Thromboembolism ,medicine ,Humans ,Genetic Predisposition to Disease ,Clinical significance ,Genetic Testing ,Intensive care medicine ,Venous Thrombosis ,Gynecology ,Medicine(all) ,business.industry ,Anticoagulants ,medicine.disease ,Patient management ,Clinical Practice ,Anticoagulant therapy ,Screening ,Surgery ,VTE recurrence ,Cardiology and Cardiovascular Medicine ,business ,Venous thromboembolism - Abstract
Venous thromboembolism is a complex disease resulting from the interactions of several risk factors from diverse origins: genetic, environmental and behavioral. Numerous studies have evidenced an association between genetic thrombophilia defects and venous thromboembolism. However, the clinical relevance of genetic thrombophilia to recurrent venous thromboembolism is not clear and the risks of long-term anticoagulant treatment usually outweigh any benefits of hereditary thrombophilia screening. Therefore, in everyday clinical practice (outside of research protocols) hereditary thrombophilia screening should be performed only in cases where such testing is likely to influence patient management.
- Published
- 2007
- Full Text
- View/download PDF